InvestorsHub Logo
Followers 17
Posts 10824
Boards Moderated 0
Alias Born 03/11/2017

Re: None

Monday, 10/21/2019 10:04:42 PM

Monday, October 21, 2019 10:04:42 PM

Post# of 44779
Pluristem's PLX-Cell Platform Has An Incredible Advantage Over ALL BIG PHARMA'S SMALL MOLECULE DRUGS AND MONOCLONAL ANTIBODIES !!! An Expert Concludes..Biosimilars For Cell Based Medicinal Products Are Not Likely To Be Possible In The Foreseeable Future ! That My Friends Is Worth many Billions More In The Future For Shareholders ! That Is Why BIG PHARMA IS COMPLETELY FREAKED-OUT ABOUT PLURISTEM THERAPEUTICS ! GIDDY-UP YAKY & ZAMI HAVE HIT A GRAND SLAMMY.. AT THE BOTTOM OF THE NINETH !!!!!!!!!!!


http://advbiols.com/documents/Bravery-AreBiosimilarCellTherapiesPossible.pdf